| Transaction in Own Shares | 07-Nov-2025 | 08:57 | RNS |
| Director/PDMR Shareholding | 06-Nov-2025 | 11:00 | RNS |
| Transaction in Own Shares | 05-Nov-2025 | 07:00 | RNS |
| Transaction in Own Shares | 04-Nov-2025 | 18:20 | RNS |
| Total Voting Rights | 03-Nov-2025 | 13:00 | RNS |
| Transaction in Own Shares | 31-Oct-2025 | 07:00 | RNS |
| 2025 Third Quarter Trading Update | 23-Oct-2025 | 07:00 | RNS |
| Directorate Change | 21-Oct-2025 | 13:40 | RNS |
| Transaction in Own Shares | 14-Oct-2025 | 07:00 | RNS |
| Transaction in Own Shares | 10-Oct-2025 | 07:00 | RNS |
| Transaction in Own Shares | 06-Oct-2025 | 07:00 | RNS |
| Transaction in Own Shares | 02-Oct-2025 | 07:00 | RNS |
| Total Voting Rights | 01-Oct-2025 | 14:08 | RNS |
| Transaction in Own Shares | 01-Oct-2025 | 07:00 | RNS |
| Transaction in Own Shares | 26-Sep-2025 | 07:00 | RNS |
| Currency | UK Pounds |
| Share Price | 9,738.00p |
| Change Today | 220.00p |
| % Change | 2.31 % |
| 52 Week High | 10,880.00p |
| 52 Week Low | 7,424.00p |
| Volume | 964,255 |
| Shares Issued | 151.97m |
| Market Cap | £14,798m |
| RiskGrade | 171 |
| Value |
|
|---|
| Price Trend |
|
|---|
| Income |
|
|---|
| Growth |
|
|---|
| Strong Buy | 1 |
| Buy | 5 |
| Neutral | 8 |
| Sell | 2 |
| Strong Sell | 2 |
| Total | 18 |

| Latest | Previous | |
|---|---|---|
| Interim | Final | |
| Ex-Div | 21-Aug-25 | 03-Apr-25 |
| Paid | 02-Oct-25 | 15-May-25 |
| Amount | 58.60¢ | 114.40¢ |
| Time | Volume / Share Price |
| 19:00 | 7,371 @ 9,738.00p |
| 11:01 | 219,502 @ 9,566.00p |
| 11:00 | 219,502 @ 9,566.00p |
| 17:12 | 2,273 @ 9,738.00p |
| 17:09 | 269 @ 9,738.00p |
| CEO | Elie Maalouf |
| CFO | Michael Glover |
You are here: research